Phesi Partners with Accenture to Release Report on RWD in Drug Development
Analytics group Phesi partnered with Accenture to release the first of several reports on the use of RWD (real world [...]
CROs Consider a Post-COVID Clinical Trial Landscape
CROs (Contract Research Organizations) are hopeful that the COVID-19 pandemic will not last forever. Jim Reilly, Vice President of Vault [...]
Remdesivir FDA Decision Alert Added to Aetion’s RWE Library
Aetion’s FDA Decision Alert Library includes examples of FDA submissions using RWE (real world evidence) and RWD (real world data). [...]
Webinar on RWE’s Role in Accelerating Drug Development
A webinar is now available featuring discussions with Drs. Nicolle Gatto, Senior Vice President of Scientific Research at Aetion; Julie [...]
Syneos Health and Science 37 Announce Partnership Aimed at RWE Integration Into Clinical Trial Design
In an effort to seamlessly incorporate RWE (real world evidence) into clinical trial design, Syneos Health and Science 37 announced [...]
Comparing ICER and IVI in Shifting Value-Based Reimbursement Landscape
The US healthcare system is transitioning from a volume- to a value-based reimbursement payment structure. Assigning value continues to be [...]
The Role of RWE in FDA Regulatory Decisions
RWE (real world evidence) and RWD (real world data) have risen in prominence when it comes to clinical trial design [...]
Preparing for the COVID-19 Economic Impact
The total burden of COVID-19 remains unknown. A toolkit from HMS (Health Management Systems) provides strategies for mitigating underlying issues [...]
Upcoming Webinar on Managed Care Pharmacy Practices and RWE
A webinar hosted by the AMCP (Academy of Managed Care Pharmacy) will take place on Thursday, April 1st from 2 [...]
Abbvie HEOR Expert Shares Thoughts on RWE and Improving Health Equity
Christopher Boone, Vice President and global head of HEOR (health economics and research outcomes) at Abbvie, recently gave an informative [...]
FDA Reveals Data Modernization Action Plan Including RWD Details
The FDA released DMAP (a Data Modernization Action Plan) in response to changes and trends in the pharma industry. Some [...]
Can RWE Improve Odds in FDA Applications for Medical Devices?
Christian Howell, Vice President and General Manager of Medical Devices and Diagnostics at Aetion, provides insight into when and how [...]
New Review on Inclusion of RWE in Regulatory Decisions
A new paper discusses the state of RWE (real world evidence) and RWD (real world data) in the context of [...]
Scientist.com Reveals Expanded HEOR, Value, and RWE Category, Good News for Both Researchers and Suppliers
Scientist.com, parent company of HealthEconomics.Com, has recently announces a rebranding initiative for its “Value, Evidence and Access Marketplace.” This online [...]
Cytel Webinar on Effectively Using RWD in Clinical Trials
The use of RWD (real world data) is on the rise. However, certain myths regarding when and how it can [...]
Panacea and IQVIA Host RWE and HEOR Webinar on Saturday, March 20th
A webinar on RWE (real world evidence) and HEOR (health economics and outcomes research) will take place on March 20th [...]
IQVIA Partners with Janssen R & D on COVID-19 Vaccine Trial, RWD To Be Utilized in Phase 3 Trial
IQVIA has announced a partnership with Janssen Research & Development, LLC. They will work together to carry out a Phase [...]
Webinar on RWE in Drug Development and FDA Guidelines, RWE Used in 75% of FDA Approvals Last Year
A new webinar features insight from key leaders at Aetion, Sanofi, and Janssen. They discuss the impacts of RWE (real [...]
Cytel Webinar Discusses How Wearables Provide Extensive RWD in Clinical Trials, Require Specific Skillset to Interpret Data
Due to their ease of use and the abundance of data gathered from them, wearable devices are expected to become [...]
Aetion Vice President Shares Insight on What RWE Means for the Medical Device Industry
Christian Howell, Vice President and General Manager of Medical Devices and Diagnostics at Aetion, shared his thoughts on how RWE [...]
Webinar on Value Communication in Pharma Features HealthEconomics.Com Founder and CEO Dr. Patti Peeples
A webinar on the importance of value communication in pharma provides important insight for medical communications professionals. Patti Peeples, RPh, [...]
RWE Solution Provider Corrona, LLC, Rebrands to become CorEvitas, Broadens Scope of Company
Corrona, LLC, has announced that it will change its company name to CorEvitas. It will also expand its offerings in [...]
Aetion’s Take on RWE Expansion in Europe
Aetion’s Ashley Jaska, Vice President of Science, and Nicholas Deltour, Vice President of Real-World Solutions, offered their insight into how [...]
Register Today for Virtual ISPOR 2021 Conference on HEOR, HTAs, and RWD
ISPOR will host its yearly conference on HEOR (health economics and outcomes research) virtually, from May 17-20. The theme of [...]
A Conversation with Gilead Leader on Impact of RWE in Drug Development
Dr. Diana Brainard, Senior Vice President and Virology Therapeutic Area Head at Gilead Sciences, provides her thoughts on the role [...]